ArticleESMO open2017
Patient-reported tolerability of adverse events in phase 1 trials.
Clémence Henon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it
ArticleESMO open2017
Clémence Henon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.